Axcel has signed an agreement to aquire a majority ownership stake in AddPro, a Swedish leading provider of IT and cloud services. AddPro’s current management team and founders will reinvest in the company alongside Axcel.

AddPro was founded 2000 in Malmö and has a total approximate revenue of SEK 800 million and close to 350 employees. AddPro is acquired from Adelis Equity Partners, founders, the management team and key employees. The transaction is subject to customary regulatory approvals. AddPro is the second investment in Axcel VI.

Vinge’s team consisted of partners Christina Kokko (M&A) and Mikael Ståhl (Banking & Finance) and associates Johanna Wiberg, Stina Bengtsson and Carl Fredrik Wachtmeister (M&A), Linn Adewald, Pauline Lagerstrand, Elias Lundin and Jolinn Uhlin (Banking & Finance), Mathilda Persson, Martin Boström and Fredrika Hjelmberg (Commercial Agreements & IT), Ilze Lukins and Anna Li (IP), Lisa Hörnqvist (GDPR), Veronika Garemark (Employment), Kristoffer Larsson (Real Estate), Kristoffer Sällfors (Public Procurement), Johan Wahlbom (Antitrust) and Nathalie Hughes (VDR assistant).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025